ABINGTON, MA, March 30, 2014 (Press-News.org) SchureMed announced today plans to present their newest and most innovative surgical positioning device at the AORN Show at McCormick Place in Chicago IL. The Schure Loc XPS Extremity Positioning System advances surgical patient positioning by combining both absolute rigid fixation of the patient's limb with unlimited range of motion both pre- and intra-operatively during shoulder arthroscopy, rotator cuff and total shoulder replacement procedures.
Unlike other devices that use bulky hydraulic systems and supplementary power units, the Schure Loc XPS employs an ingenious single-trigger methodology to relax the entire unit for positioning and repositioning as required; locking again, in any new position, when the trigger is released. This allows the whole surgical team to focus on the open or arthroscopic limb procedure and decreases surgeon fatigue.
About SchureMed
SchureMed is a global leader in improving patient positioning through better design, clinical efficiency and surgical suite safety. Our mission is to help surgeons treat their patients at the highest level of care - we do this through a highly-focused research and design process that looks to overcome clinical obstacles and improve patient outcomes. We support this mission by manufacturing and building our own devices to incredibly high standards and delivering our products around the globe. See them at AORN at Booth # 5128 or find their newest catalog of medical devices that improve surgical suite efficiency, go to their website at www.schuremed.com.
About AORN
AORN or The Association of periOperative Registered Nurses each year sponsors a Surgical Conference and Expo which takes place in 2014 at the McCormick Place in Chicago IL. AORN currently represents more than 41,000 registered nurses in the U.S. and abroad in a variety of surgical, management and research capacities as it has done since 1949. Use this link for more information about www.AORN.com
SchureMed to Unveil Schure Loc XPS Medical Device at AORN in Chicago
Innovative surgical positioning device vastly improves operating suite performance and efficiency.
2014-03-30
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Texas Based Modern Intellects Artist Gift Releases The Trip EP
2014-03-29
The release of Gift's EP "The Trip" has been eagerly awaited by fans since mid-2013, the uniquely creative video countdown gave fans but a glimpse inside the mind of the independent rapper and the creative process of the project, leaving listeners and viewers wanting more.
Gift first began writing at 16 years old after a serious hamstring injury that ended his future in track and field, but ended up being what would pave the way for his future. Fans have the choice of downloading the EP for free or making a donation by visiting www.giftrapsmusic.com or the artist's SoundCloud ...
Relaxed blood pressure guidelines cut millions from needing medication
2014-03-29
DURHAM, N.C. – New guidelines that ease the recommended blood pressure could result in 5.8 million U.S. adults no longer needing hypertension medication, according to an analysis by Duke Medicine researchers.
The findings are the first peer-reviewed analysis to quantify the impact of guidelines announced in February by the Eighth Joint National Committee. In a divisive move, the committee relaxed the blood pressure goal in adults 60 years and older to 150/90, instead of the previous goal of 140/90.
Blood pressure goals were also eased for adults with diabetes and kidney ...
Study estimates proportion of adults affected by new blood pressure guideline
2014-03-29
Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions.
Ann Marie Navar-Boggan, M.D., Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues quantified the proportion of adults potentially ...
US, European cholesterol guidelines differ in statin use recommendations
2014-03-29
Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all men and two-thirds of women, proportions exceeding those of the other guidelines, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions.
The common approach in cardiovascular disease (CVD) primary prevention is to identify individuals at high enough risk to justify more intensive lifestyle ...
Analysis supports use of risk equations to guide statin therapy
2014-03-29
In an analysis of almost 11,000 patients, an assessment of equations that help guide whether a patient should begin taking a statin (cholesterol lowering medication) found that observed and predicted 5-year atherosclerotic cardiovascular disease risks were similar, suggesting that these equations are helpful for clinical decision making, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published ...
Celiac disease linked to increased risk of coronary artery disease
2014-03-29
People with celiac disease may have a near two-fold increased risk of coronary artery disease compared with the general population, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.
The study is the first to look at the association between celiac disease and coronary artery disease and adds to the evolving understanding of how systemic inflammation and autoimmune processes might influence cardiovascular disease development. Data also showed a slightly higher risk of stroke among people with celiac disease compared ...
Are statins good for your love life?
2014-03-29
Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.
Erectile dysfunction is common in older men, especially among those with cardiovascular risk factors where cholesterol-lowering statins are frequently prescribed. Previous research has suggested a negative association between statin therapy and testosterone levels, leading to ...
Study finds astronauts' hearts become more spherical in space
2014-03-29
New findings from a study of 12 astronauts show the heart becomes more spherical when exposed to long periods of microgravity in space, a change that could lead to cardiac problems, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.
With implications for an eventual manned mission to Mars, the findings represent an important step toward understanding how a spaceflight of 18 months or more could affect astronauts' heart health.
"The heart doesn't work as hard in space, which can cause a loss of muscle mass," ...
Daylight saving impacts the timing of heart attacks
2014-03-29
Still feeling the residual effects of springing ahead for daylight saving time? The hour of sleep lost – or gained – may play a bigger, perhaps more dangerous role in our body's natural rhythm than we think. It seems moving the clock forward or backward may alter the timing of when heart attacks occur in the week following these time changes, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.
Data from the largest study of its kind in the U.S. reveal a 25 percent jump in the number of heart attacks occurring the ...
Too many diet drinks may spell heart trouble for older women
2014-03-29
It appears healthy postmenopausal women who drink two or more diet drinks a day may be more likely to have a heart attack, stroke or other cardiovascular problems, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.
In fact, compared to women who never or only rarely consume diet drinks, those who consumed two or more a day were 30 percent more likely to suffer a cardiovascular event and 50 percent more likely to die from related disease. Researchers analyzed diet drink intake and cardiovascular risk factors from ...
LAST 30 PRESS RELEASES:
Black youth, especially Black girls, use mental health services less than their White peers
Canada must protect youth from sports betting advertising
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
[Press-News.org] SchureMed to Unveil Schure Loc XPS Medical Device at AORN in ChicagoInnovative surgical positioning device vastly improves operating suite performance and efficiency.